Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Halozyme Therapeutics (GB:0J2O)
LSE:0J2O
Halozyme (0J2O) Ownership - Who Owns Halozyme?
1 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 26, 2024 | Michael Labarre Svp, Cto | Bought | $130160 |
| Aug 15, 2023 | James M. Daly Director | Sold | $874500 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $306065 | |
| Dec 31, 2023 | Bought | $421454 | |
| Dec 31, 2023 | Bought | $717837 | |
| Dec 31, 2023 | Bought | $3617940 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 193,505 | Insider | ― | 7,474,131 | |
| 364,320 | Insider | ― | 14,071,860 | |
| 676,744 | Insider | ― | 26,139,237 | |
| 338,051 | Insider | ― | 13,057,220 | |
| 119,755 | Insider | ― | 4,625,537 | |
| 179,833 | Insider | ― | 6,946,050 | |
| 14,092,771 | Insider | ― | 544,333,280 | |
| 13,638 | Insider | ― | 526,768 | |
| 66,815 | Insider | ― | 2,580,729 | |
| 66,373 | Insider | ― | 2,563,657 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 499,910 | Institution | ― | 19,309,024 | |
| 295,322 | Institution | ― | 11,406,812 | |
| 174,165 | Institution | ― | 6,727,123 | |
| 17,290 | Institution | ― | 667,826 | |
| 500,000 | Institution | ― | 19,312,500 | |
| 60,285 | Institution | ― | 2,328,508 | |
| 868,111 | Institution | ― | 33,530,787 | |
| 26,433 | Institution | ― | 1,020,975 | |
| 81,356 | Institution | ― | 3,142,376 | |
| 24,213 | Institution | ― | 935,227 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Halozyme Therapeutics (GB:0J2O)?
Currently, no data Available
What percentage of Halozyme Therapeutics (GB:0J2O) stock is held by institutional investors?
Currently, no data Available
What percentage of Halozyme Therapeutics (GB:0J2O) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Halozyme Therapeutics (GB:0J2O)?
Connie Matsui owns the most shares of Halozyme Therapeutics (GB:0J2O).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.